HeartSciences (HSCSW) Gross Profit (2021 - 2025)

HeartSciences (HSCSW) has reported Gross Profit for 5 consecutive years, with $1411.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Gross Profit changed N/A year-over-year to $1411.0; the trailing twelve-month figure through Apr 2026 stood at $5021.0 (down 60.18% YoY), and the FY2026 full-year result was $2551.0, up 3.28% from the prior year.
• Gross Profit grew to $1411.0 in Q4 2025 per HSCSW's latest filing, from $1140.0 in the prior quarter.
• Across five years, Gross Profit topped out at $10139.0 in Q1 2024 and bottomed at $1140.0 in Q3 2025.
• Historically, Gross Profit has averaged $2637.7 across 5 years, with a median of $1807.0 in 2021.
• The sharpest annual moves came in 2023 and 2024: Gross Profit slumped 36.9% in 2023, then jumped 752.02% in 2024.
• Over 5 years, Gross Profit stood at $1728.0 in 2021, then plunged by 32.64% to $1164.0 in 2022, then soared by 104.47% to $2380.0 in 2023, then soared by 326.01% to $10139.0 in 2024, then sank by 86.08% to $1411.0 in 2025.
• According to Business Quant data, Gross Profit over the past three periods registered $1411.0, $1140.0, and $2470.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.